Current issues in pharmaceutical reimbursement
- 15 January 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 65 (2_Suppleme), S11-S26
- https://doi.org/10.2146/ajhp070620
Abstract
Purpose. Six issues in pharmaceutical reimbursement arising from recent or proposed changes in Medicare rules or rates or the health care environment are described, along with possible strategies for addressing these issues.Keywords
This publication has 6 references indexed in Scilit:
- Pay for Performance, Quality of Care, and Outcomes in Acute Myocardial InfarctionPublished by American Medical Association (AMA) ,2007
- Patient assistance programs and patient advocacy foundations: Alternatives for obtaining prescription medications when insurance failsAmerican Journal of Health-System Pharmacy, 2006
- Quality‐of‐life and health benefits of early treatment of mild anemiaCancer, 2006
- Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of HematologyJournal of Clinical Oncology, 2002
- Cost of Outpatient Blood Transfusion in Cancer PatientsJournal of Clinical Oncology, 2000
- What are cancer patients willing to pay for prophylactic epoetin alfa?Cancer, 1998